【24h】

Antimycobacterial activity of Pichia pastoris-derived mature bovine neutrophil β-defensins 5

机译:巴斯德毕赤酵母来源的成熟牛中性粒细胞β-防御素5的抗分枝杆菌活性

获取原文
获取原文并翻译 | 示例
       

摘要

Tuberculosis (TB) is an ongoing threat to global health, and the lack of effective therapies for treating it is also a global problem. Previous studies have shown that human cathelicidin and defensins have effective antimicrobial activity against Mycobacterium spp. To our knowledge, there are no reports on the antimycobacterial effects of bovine neutrophil β-defensins so far. Here, we identified the antimicrobial effect of mature bovine neutrophil β-defensins (mBNBD) 5 against Mycobacterium infection both in vitro and in vivo. The mBNBD5 protein was expressed in Pichia pastoris. To increase the yield of β-defensins, a purification method was employed by adding a 6-His·tag to the C-terminus of the mBNBD5 gene. Our results indicated that recombinant mBNBD5 protein was successfully expressed and purified from Pichia pastoris with intact antimicrobial activity. The recombinant protein exhibited potent bactericidal activity in vitro against M. smegmatis and M. bovis, with a dose-dependent manner and a time-dependent manner. The electron microscope results showed that the bacterial cell wall of M. bovis was disrupted when incubated with mBNBD5 for 72 h. Our data also indicated that the exogenous addition of mBNBD5 could reduce the survival of Mycobacterium spp., especially M. tuberculosis and M. bovis in RAW 264.7 macrophages. These results provide foundations for the development of mBNBD5 as a potential new therapeutic agent for TB treatment.
机译:结核病(TB)对全球健康构成持续威胁,缺乏有效的治疗方法也是一个全球性问题。先前的研究表明,人cathelicidin和防御素对分枝杆菌属具有有效的抗菌活性。据我们所知,迄今尚无关于牛中性粒细胞β-防御素的抗分枝杆菌作用的报道。在这里,我们确定了成熟的牛嗜中性粒细胞β-防御素(mBNBD)5在体外和体内对分枝杆菌感染的抗菌作用。 mBNBD5蛋白在巴斯德毕赤酵母中表达。为了提高β-防御素的产量,采用了一种纯化方法,在mBNBD5基因的C末端添加6-His·tag。我们的结果表明重组mBNBD5蛋白已成功从具有完整抗微生物活性的巴斯德毕赤酵母中表达和纯化。该重组蛋白在体外对耻垢分枝杆菌和牛分枝杆菌具有有效的杀菌活性,呈剂量依赖性和时间依赖性。电镜观察结果表明,与mBNBD5孵育72小时,牛分枝杆菌的细菌细胞壁被破坏。我们的数据还表明,外源添加mBNBD5可能会降低RAW 264.7巨噬细胞中分枝杆菌的存活,尤其是结核分枝杆菌和牛分枝杆菌。这些结果为开发mBNBD5作为结核病治疗的潜在新治疗剂提供了基础。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号